Open-access model – announcement

The IPECAD Alzheimer’s disease model (Green et al, 2019), is available on an open-access basis.  It has been developed by the IPECAD Modelling Group as a framework to model disease progression across Alzheimer’s disease (AD) and to assess the costs and outcomes associated with the condition, and the cost-effectiveness of interventions for people affected by AD, using the scenario of a future disease modifying therapies (DMT) for people with mild cognitive impairment (MCI) due to AD.

A description of the model (version 1.0) will be published open-access soon in the journal Alzheimer’s and Dementia: the journal of the Alzheimer’s Association.

search previous next tag category expand menu location phone mail time cart zoom edit close